FDA Issues Stronger Warning on Side Effects of Fluoroquinolones

Share this content:
FDA Issues Stronger Warning on Side Effects of Fluoroquinolones
FDA Issues Stronger Warning on Side Effects of Fluoroquinolones

FRIDAY, May 13, 2016 (HealthDay News) -- Stronger warnings about the possible side effects of fluoroquinolones were issued Thursday by the U.S. Food and Drug Administration.

The agency said these side effects are concerning enough that health care providers should not prescribe these drugs to people with sinusitis, bronchitis, or uncomplicated urinary tract infections when they have other treatment options.

Some of the reported side effects include pain in the tendons, joints, or muscles; a "pins-and-needles" sensation; confusion; and hallucinations. Anyone who experiences these symptoms while taking these drugs should contact their health care provider immediately, the agency advised in a statement.

The FDA had issued two previous warnings about some of the side effects associated with these drugs, in 2008 and 2013, but this is the first time the agency is recommending that health care providers not prescribe them for certain patients.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

CDC Concerned About Falling Flu Vaccination Rates

CDC Concerned About Falling Flu Vaccination Rates

Decline among vulnerable older adults is of particular concern

One in Five With Non-Valvular A-Fib Receiving Digoxin

One in Five With Non-Valvular A-Fib Receiving Digoxin

Indication for digoxin use was considered inappropriate in 59.8 percent in Turkish cohort

Rapid, Successful Response to ART for Many Patients With HIV

Rapid, Successful Response to ART for Many Patients ...

Factors associated with virological success include having undetectable viral load, use of three drugs

is free, fast, and customized just for you!

Already a member?

Sign In Now »